Cargando…

Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial

BACKGROUND: Chronic spontaneous urticaria (CSU) is characterized by the spontaneous appearance of wheals, angioedema, or both for > 6 weeks. Continuous treatment with H1-antihistamines is used as a first-line treatment for CSU. However, H1-antihistamine treatment leads to absence of symptoms in l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukunaga, Atsushi, Oda, Yoshiko, Washio, Ken, Omori, Takashi, Kakei, Yasumasa, Hide, Michihiro, Nishigori, Chikako
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945582/ https://www.ncbi.nlm.nih.gov/pubmed/31906999 http://dx.doi.org/10.1186/s13063-019-3878-2

Ejemplares similares

Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022)

Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
por: Wolthers, Ole D.
Publicado: (2013)

One‐year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases
por: Yagami, Akiko, et al.
Publicado: (2016)

Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia
por: Cheong, Wai Kwong, et al.
Publicado: (2022)

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013)

The safety and tolerability profile of bilastine for chronic urticaria in children
por: Papadopoulos, Nikolaos G., et al.
Publicado: (2019)

Bilastine vs. hydroxyzine: occupation of brain histamine H(1)-receptors evaluated by positron emission tomography in healthy volunteers
por: Farré, Magí, et al.
Publicado: (2014)

Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
por: Staevska, Maria T
Publicado: (2016)

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria
por: Krause, K, et al.
Publicado: (2013)

Cholinergic Urticaria: Subtype Classification and Clinical Approach
por: Fukunaga, Atsushi, et al.
Publicado: (2022)

Differential Regulation of Bilastine Affinity for Human Histamine H(1) Receptors by Lys 179 and Lys 191 via Its Binding Enthalpy and Entropy
por: Akimoto, Hayato, et al.
Publicado: (2021)

Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
por: Mösges, Ralph, et al.
Publicado: (2016)

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
por: Wang, Xue Yan, et al.
Publicado: (2016)

IgE receptor responsiveness of basophils in chronic inducible urticaria
por: Mizuno, Mayuko, et al.
Publicado: (2022)

Histamine H1 antagonists and clinical characteristics of febrile seizures
por: Zolaly, Mohammed A
Publicado: (2012)

Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria
por: Rodríguez, Mónica, et al.
Publicado: (2020)

Effects of Olopatadine Hydrochloride, a Histamine H(1) Receptor Antagonist, on Histamine-Induced Skin Responses
por: Hashimoto, Takashi, et al.
Publicado: (2010)

Synthesis and Dual Histamine H(1) and H(2) Receptor Antagonist Activity of Cyanoguanidine Derivatives
por: Sadek, Bassem, et al.
Publicado: (2013)

Cetirizine a histamine H1 receptor antagonist improves viral myocarditis
por: Matsumori, Akira, et al.
Publicado: (2010)

Histamine H(1) antagonist levocetirizine as a potential cause of lung injury
por: Endo, Satoshi, et al.
Publicado: (2015)

Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?
por: Qu, Changbo, et al.
Publicado: (2021)

Suppression of Osteopontin Functions by Levocetirizine, a Histamine H(1) Receptor Antagonist, In Vitro
por: Komatsuzaki, Toshimitsu, et al.
Publicado: (2013)

Histamine H(1) receptor antagonists enhance the efficacy of antibacterials against Escherichia coli
por: Bruer, G. G., et al.
Publicado: (2019)

Effect of Ions and Sequence Variants on the Antagonist Binding Properties of the Histamine H(1) Receptor
por: Conrad, Marcus, et al.
Publicado: (2022)

Exploring the Effect of Cyclization of Histamine H(1) Receptor Antagonists on Ligand Binding Kinetics
por: Wang, Zhiyong, et al.
Publicado: (2021)

Multiple Targeting Approaches on Histamine H(3) Receptor Antagonists
por: Khanfar, Mohammad A., et al.
Publicado: (2016)

Target switch of centipede toxins for antagonistic switch
por: Yang, Shilong, et al.
Publicado: (2020)

The Histamine H(4) Receptor Participates in the Neuropathic Pain-Relieving Activity of the Histamine H(3) Receptor Antagonist GSK189254
por: Borgonetti, Vittoria, et al.
Publicado: (2022)

Histamine and H(1)-histamine receptors faster venous circulation
por: Galajda, Zoltan, et al.
Publicado: (2011)

Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department
por: Leceta, Amalia, et al.
Publicado: (2017)

Effect of histamine H1 and H2 receptor antagonists, microinjected into cerebellar vermis, on emotional memory consolidation in mice
por: Gianlorenço, A.C.L., et al.
Publicado: (2014)

Antiseizure Properties of Histamine H(3) Receptor Antagonists Belonging 3,4-Dihydroquinolin-2(1H)-Ones
por: Hua, Yi, et al.
Publicado: (2023)

Histamine H1 receptor antagonists selectively kill cisplatin-resistant human cancer cells
por: Matsumoto, Nobuki, et al.
Publicado: (2021)

Anticonvulsant effects of isomeric nonimidazole histamine H(3) receptor antagonists
por: Sadek, Bassem, et al.
Publicado: (2016)

Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients
por: De, Abhishek, et al.
Publicado: (2021)

Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study
por: Sinha, Vishakha V., et al.
Publicado: (2023)

Effects of administration of histamine and its H(1), H(2), and H(3) receptor antagonists into the primary somatosensory cortex on inflammatory pain in rats
por: Tamaddonfard, Esmaeal, et al.
Publicado: (2014)

Bilastine: new insight into antihistamine treatment
por: Ridolo, Erminia, et al.
Publicado: (2015)

Elucidation of Inverse Agonist Activity of Bilastine
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2020)

Signaling Pathway of Histamine H(1) Receptor-Mediated Histamine H(1) Receptor Gene Upregulation Induced by Histamine in U-373 MG Cells
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v6van69nrhp9o9qhm0v05l7ol1